Search
Search
Let's Shake 2019
This event supports Parkinson's Disease Research.
Michelangelo Banquet Centre
1555 Upper Ottawa Street,
Hamilton ON Map
Tickets $55.00 per person
Doors Open 6:00 p.m.
Dinner 7:00 p.m.
Special Guests
4 Course Meal
Cash Bar
Live Entertainment Featuring
Crank, and Matthew Burdett
Chris Chambers
And Special Guest, Gord Lewis of Teenage Head!
Silent Auction
Door Prizes and more!
For more information, visit the London Health Sciences Foundation.
News and Media
Lawson LEADS Email Newsletter
Sign up to receive the Lawson Leads email newsletter.
- Lawson LEADS November 2025 newsletter and the Research Success Supplement
- Lawson LEADS October 2025 newsletter and the Research Success Supplement
- Lawson LEADS September 2025 newsletter and the Research Success Supplement
- Lawson LEADS July 2025 newsletter and the Research Success Supplement
- Lawson LEADS June 2025 newsletter and the Research Success Supplement
- Lawson LEADS May 2025 newsletter and the Research Success Supplement
- Lawson LEADS April 2025 newsletter and the Research Success Supplement
- Lawson LEADS March 2025 newsletter and the Research Success Supplement
- Lawson LEADS February 2025 newsletter and the Research Success Supplement
- Lawson LEADS January 2025 newsletter
Prime Minister announces support for health research
Health researchers in London and across Canada welcomed news that the federal government will provide urgently-needed financial support for research teams whose work has been largely shut down by the COVID-19 pandemic.
Prime Minister Justin Trudeau has announced $450 million in new funding to help Canada’s academic research community during the COVID-19 pandemic.
“Research staff in Canada are the source of new innovations and ideas that help keep us healthy, protect our environment, and drive our economy. We are fortunate to have some of the world’s brightest minds. We are making sure Canadian universities and health research institutes have the support they need to sustain their research capacity through this difficult situation, and continue to attract and retain talent, for the benefit of all Canadians,” says The Rt. Hon. Justin Trudeau, Prime Minister of Canada.
The investment will:
- Provide wage supports to universities and health research institutes, so they can retain their research staff who are funded from industry or philanthropic sources and are unable to access some of the government’s existing COVID-19 support measures. This would apply even if their work has been temporarily suspended. The government will provide up to 75 per cent per individual, with a maximum of $847 per week.
- Support universities and health research institutes to maintain essential research-related activities during the crisis, and to ramp back up to full research operations once physical distancing measures are lifted. This will cover up to 75 per cent of total eligible costs, and will support activities such as the safe storage of dangerous substances and restarting data sets that were interrupted during the pandemic.
“Research personnel in our universities and health research institutes are significant drivers of science, discovery, and innovation in Canada. By providing these institutions with immediate support, we continue to nurture Canada’s talent pipeline and sustain our innovation capacity, while helping to mitigate the negative impacts of COVID-19 on the research community,” says The Hon. Navdeep Bains, Minister of Innovation, Science and Industry.
This announcement follows a tremendous effort by organizations and individuals across Canada over the course of this pandemic to secure support for hospital-based research. From outreach and meetings to letters and media interviews, many advocacy-based initiatives were undertaken to bring this important issue to the attention of key decision-makers. HealthCareCAN spearheaded these efforts, working tirelessly on behalf of the national health research community.
Lawson is extremely thankful to the federal government for recognizing the critical importance of protecting Canada’s research enterprise and providing urgently-needed financial support. “While we know financial pressure remains, this will help to keep research teams intact while research has been interrupted and provide assistance for when research activities gradually resume,” says Dr. David Hill, Lawson Scientific Director.
A special thank you to local MP Peter Fragiskatos for London North Centre who took up this issue in Ottawa. His strong leadership and representation made the key difference in successfully securing this new funding.
“Tackling the COVID-19 crisis in Canada has required an all-hands on deck approach and Canada’s health researchers have answered the call by suspending all other crucial hospital-based research to meet the challenge,” adds Dr. David Hill. “With this federal support we can now work to ensure that we can maintain other critically needed research on other diseases even as we pursue what promises to be a lengthy battle against COVID-19.”
Background:
- Canadian healthcare-based research is a $3 billion annual sector of the economy and employs 50,000 highly skilled researchers and other staff across the country.
- Health research is one of Canada’s great national achievements and biomedical research conducted in Canada is at the forefront of current essential research and clinical trials around COVID-19.
- This work is fundamental to life in a society and a key driver for progress, innovation and the economy. Canada’s health researchers are global leaders in driving improvements in disease prevention, diagnosis, treatment and care.
- Ontario’s research hospitals have long been the engines of health invention and discovery in provincial and national innovation. From Ottawa, London, Toronto, Kingston, Sudbury and Thunder bay, the more than 20,000 researchers and staff at these hospitals are driven by their passion to improve health.
See also:
- Prime Minister announces support for research staff in Canada – Government news release
- Canada’s health research enterprise welcomes federal support – HealthCareCAN media release
- OHA Media Statement re: Federal Government Supporting Ontario’s Hospital-Based Research Enterprise
See the Line: Concussion Research and Awareness - CME & Symposium
Learn the latest in sport related brain injury evaluation and treatment - presented by the Schulich School of Medicine & Dentistry. Once again this year, we will be offering a full-day CME inclusive of the afternoon See the Line Community Symposium that will educate you on the latest in concussion research - hearing from world-class medical experts, health care advocates and professional athletes through the following series of events:
Morning: Continuing Medical Education (CME)
Registration: Registration is required. Registration fees apply for physicians and allied health care professionals.
Confirmed speakers include Dr. Lisa Fischer and Dr. Jason Mihalik. More speakers and a formal agenda will be announced in the coming weeks. Keep checking back for more information.
Who Attends? Physicians, allied health care professionals, medical and nursing students, residents
CME Session Options:
Full-day CME (8:30 a.m. - 5:00 p.m.):
Morning session in Dental Science Building, Rm. 1002, Western University
Afternoon session in Natural Sciences Centre, Rm. 145, Western University
* $100 for physicians and allied health care professionals. Residents and medical students are free.
Morning CME only (8:30 a.m. - 12:00 p.m.):
Dental Science Building, Rm. 1002, Western University
* $100 for physicians and allied health care professionals. Residents and medical students are free.
Afternoon Symposium only (1:00 - 5:00 p.m.):
Natural Sciences Centre, Rm. 145, Western University
* Attend the complimentary Community Information Symposium and earn CME credits by registering for the afternoon Symposium through Continuing Professional Development (CPD).
* You must register through CPD to earn CME credits.
Afternoon: Community Information Symposium
Time: 1:00 - 5:00 p.m.
Location: Natural Sciences Centre, Rm. 145, Western University
Registration: Registration is required. Free for all to attend.
Learn the latest concussion news and research from an exciting lineup of world-class experts and researchers. You will also hear personal stories from a panel of professional athletes about the impact concussions have had on their careers and lives.
Confirmed speakers include Dr. Douglas Fraser, Dr. David Mulder and Ms. Lisa MacLeod, MPP. The 2016 line up of athletes will be announced in the coming weeks. Keep checking back for more information.
Who Attends? Coaches, athletes, teams, parents, educators, students, health care professionals and media
For more information, including event registration please visit the See the Line website.
Shocking number of heart attack patients suffer dangerous hemorrhage following lifesaving treatment, study shows
MEDIA RELEASE
For immediate release
February 10th, 2022
LONDON- A heart attack can be deadly, but there are effective lifesaving procedures if treated in time. The most common procedure is called reperfusion therapy, which is when the blocked coronary artery causing the heart attack is opened up and a stent is placed inside to let blood flow freely again.
In a recent published study by a multi-center research team at Lawson Health Research Institute, St. Joseph’s Health Care London and a number of other institutions across the globe, scientists examine a condition called reperfusion injury, a problem that can take place following reperfusion therapy.
“When you open up the coronary artery in someone experiencing a heart attack the blood starts to flow. However, we found there are a number of factors that lead to other injuries due to opening up the vessel,” explains Dr. Rohan Dharmakumar, Executive Director of the Krannert Cardiovascular Research Center at Indiana University. “Opening up the coronary artery, although lifesaving and necessary, can at times cause significant reperfusion injury which is a concept that had yet to be scientifically proven until now.”
For example, when the blocked coronary artery is opened up with reperfusion therapy the blood flowing into narrower vessels can cause the smaller vessels to burst and cause internal bleeding within the heart muscle, which is called myocardial hemorrhage.
“Those who experience a myocardial hemorrhage have a much larger piece of their heart muscle die than those who don’t have hemorrhage,” says Dr. Frank Prato, Program Lead of Lawson’s Imaging Research Program and Assistant Scientific Director at Lawson. “We have been able to show that if there is hemorrhage due to reperfusion injury, the size of the dead tissue within the heart grows, which then can ultimately lead to heart failure.”
After studying 70 patients with heart attacks, the research team was able to show reperfusion injury led to hemorrhage in excess of 50 per cent of patients who were being treated for a heart attack.
“The outcome isn’t immediate death, but heart failure that can start a few years after the heart attack,” says Dr. Dharmakumar. “So even though we are saving people initially from a heart attack, we are still losing a lot of people to heart failure within the first five years.”
This discovery was made possible through the use of Lawson’s cyclotron, a machine used to make isotopes for advanced PET/MRI scans at St. Joseph’s Health Care London.
“To validate the study with a PET/MRI we needed a specific radioactive isotope called nitrogen 13 ammonia,” explains Dr. Mike Kovacs, Scientist and Director of Lawson’s Cyclotron Facility. “We were able to create this isotope and went through Health Canada approval, so now we can use this not only in preclinical models but with human patients as well.”
The study has been published in the Journal of American College of Cardiology. The findings will now allow the research team to examine different forms of therapies that can be used in combination with reperfusion therapy to improve patient outcomes.
-30-
ABOUT LAWSON HEALTH RESEARCH INSTITUTE
Lawson Health Research Institute is one of Canada’s top hospital-based research institutes, tackling the most pressing challenges in health care. As the research institute of London Health Sciences Centre and St. Joseph’s Health Care London, our innovation happens where care is delivered. Lawson research teams are at the leading-edge of science with the goal of improving health and the delivery of care for patients. Working in partnership with Western University, our researchers are encouraged to pursue their curiosity, collaborate often and share their discoveries widely. Research conducted through Lawson makes a difference in the lives of patients, families and communities around the world. To learn more, visit www.lawsonresearch.ca.
For more information, please contact:
Celine Zadorsky
Communications Consultant & External Relations
Lawson Health Research Institute
T: 519-685-8500 ext. 75664
C. 519-619-3872
@email
www.lawsonresearch.ca/news-events
Senior Media Relations Consultant
Communications & Public Engagement
T: 519-685-8500 ext. 73502
Celine.zadorsky@lhsc.on.ca